Bifunctional Duocarmycin Analogues as Inhibitors of Protein Tyrosine Kinases
- 8 January 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 82 (1) , 16-26
Abstract
Bifunctional duocarmycin analogues are highly cytotoxic compounds that have been shown to be irreversible aldehyde dehydrogenase 1 inhibitors. Interestingly, cells with low aldehyde dehydrogenase 1 expression are also sensitive to bifunctional duocarmycin analogues, suggesting the existence of another target. Through in silico approaches, including principal component analysis, structure-similarity search, and docking calculations, protein tyrosine kinases, and especially the vascular endothelial growth factor receptor 2 (VEGFR-2), were predicted as targets of bifunctional duocarmycin analogues. Biochemical validation was performed in vitro, confirming the in silico results. Structural optimization was performed to mainly target VEGFR-2, but not aldehyde dehydrogenase 1. The optimized bifunctional duocarmycin analogue was synthesized. In vitro assays revealed this bifunctional duocarmycin analogue as a strong inhibitor of VEGFR-2, with low residual aldehyde dehydrogenase 1 activity. Altogether, studies revealed bifunctional duocarmycin analogues as a new class of naturally derived compounds that express a very high cytotoxicity to cancer cells overexpressing aldehyde dehydrogenase 1 as well as VEGFR-2.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst
- Deutsche Forschungsgemeinschaft (GSC-4)
This publication has 48 references indexed in Scilit:
- Selective Cancer Therapy by Extracellular Activation of a Highly Potent Glycosidic Duocarmycin AnalogueMolecular Pharmaceutics, 2013
- Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cellsInternational Journal of Oncology, 2012
- Methyl Effects on Protein–Ligand BindingJournal of Medicinal Chemistry, 2012
- CheS-Mapper - Chemical Space Mapping and Visualization in 3DJournal of Cheminformatics, 2012
- Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer CellsAngewandte Chemie International Edition, 2012
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KITPLOS ONE, 2009
- Protein structure prediction on the Web: a case study using the Phyre serverNature Protocols, 2009
- KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsProceedings of the National Academy of Sciences, 2009
- Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitorBiochemical and Biophysical Research Communications, 2007
- The Protein Data BankNucleic Acids Research, 2000